We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cooling Cap Helps Chemotherapy Patients Preserve Their Hair

By HospiMedica International staff writers
Posted on 20 Dec 2021
A novel portable scalp cooling system (PSCS) is designed to help those undergoing chemotherapy avoid treatment-induced hair loss (alopecia). More...


The Cooler Heads (San Francisco, CA, USA) Amma device is a wearable cap designed to provide cooling therapy by circulating a water/isopropyl alcohol (IPA) mixture at a pre-set temperature and flow rate while placed firmly and securely on the patient’s head. The self-contained, electrically-powered refrigeration unit is programmed via a touchscreen controller with a menu-driven, graphical user interface. The controller is integrated into the refrigeration unit to allow healthcare professional to directly initiate, monitor, and complete the scalp cooling process.

Amma is first shipped independently to the patient, who is trained on how to use the system, and directed to bring it to the chemotherapy session. When the infusion therapy is concluded, two more hours of scalp cooling are delivered, during which patients unplug the device from the power outlet and continue treatment while in the car and in the comfort of their home. Once cooling is complete, the patient simply stores the device away and brings it with them for their next infusion. When they are done with chemotherapy, the Amma device is shipped back to Cooler Heads.

“Cancer patients undergoing chemo are dealing with the hardest challenge one can face; keeping their hair is critical to their mental health, their sense of self, and their recovery process,” said Kate Dilligan, CEO of Cooler Heads. “Scalp cooling is an effective way for cancer patients to save their hair, but existing methods are prohibitively expensive and difficult to use.”

Alopecia is a transient and mostly reversible consequence of systemic cytotoxic chemotherapy, as it attacks rapidly dividing cells in the body, including the dividing hair matrix cells. Alopecia can be psychologically and socially devastating; for some, the emotional trauma may be so severe as to lead to refusing or delaying further treatment. Recovery generally requires a period of several months to a year, amplifying the impact of the disease and its treatment.

Related Links:
Cooler Heads


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The BathMat is positioned beneath the sheet under the patient’s upper body to lift and reposition them with ease (Photo courtesy of the University of Bath)

Inflatable Device Streamlines Repositioning of Proned Ventilated Patients

Prone ventilation is a key intervention for severe respiratory failure and acute respiratory distress syndrome, but repositioning sedated, ventilated patients is labor-intensive and time-consuming.... Read more

Surgical Techniques

view channel
Image: Notre Dame’s Professor Yanliang Zhang and Yuxuan Liao, doctoral student and lead author of the study. (Photo by Wes Evard / University of Notre Dame’s College of Engineering)

Hybrid Bioprinting Platform Creates Capillary-Scale Vascular Networks

More than 100,000 people in the United States await organ transplants, and a new candidate is added every 10 minutes. Even when surgery succeeds, recipients face lifelong immunosuppression, infection risk... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.